Gubra — December 2025
-
Oversigt: Nyt nummer af ØU Lice Science – Vigtige fedme fase 1 data i 2026 kan løfte Gubra https://proinvestor.com/investornyt/1389962/oversigt-nyt-nummer-af-ou-lice-science-vigtige-fedme-fase-1-data-i-2026-kan-lofte-gubra
-
Gubra: Positivt, men der er "langt til Tipperary" https://proinvestor.com/boards/130197
-
Boehringer Ingelheim fremmer næste generations triple-agonist peptid til behandling af fedme til mellemstadieudvikling https://proinvestor.com/investornyt/1390937/boehringer-ingelheim-fremmer-naeste-generations-triple-agonist-peptid-til-behandling-af-fedme-til-mellemstadieudvikling
-
(Fra MedWatch)
-
Insiderkøb på 10000 stk til kurs 488 i dag
-
Af best.medlem Niels Vrang
-
Gubra-bestyrelsesmedlem køber aktier for 4,9 mio. kr. https://proinvestor.com/investornyt/1394480/gubra-bestyrelsesmedlem-kober-aktier-for-49-mio-kr
-
Kort video..
I denne nytårsspecial fokuserer Helge Larsen på de mest populære selskaber på ProInvestor.com inden for fedmesektoren og giver sit bud på, hvordan det kommende år tegner for dem hver især. https://proinvestor.com/boards/130518
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind